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K+ channel openers elicit K+ currents in follicle-enclosed Xenopus oocytes. The most potent activators are the pinacidil derivatives PI075 and 
PlO60. The rank order of potency to activate K+ currents in follicle-enclosed oocytes was: P1075 (&,,:5 PM)> P1060 (k,,: 12 PM)> BRL38227 
(lemakalim) (&,,:77 FM)> RP61419 (K,,,:lOO PM)> (-)pinacidil (&,,:300 PM). Minoxidil sulfate. nicorandil. RP49356 and diaaoxide were inef- 
fective. Activation by the K+ channel openers could be abolished by the antidiabetic sulfonylurea glibenclamide. It was not affected by the blocker 
of the (X+-activated K+ channels charybdotoxin. The various K’ channel openers failed to activate glibenclamide-sensitive K+ channels in defolli- 
culated oocytes. but BRL derivatives (&,s for BRL38226 is 150 PM) and RP61419 inhibited a background current. The channel responsible for 
this background current is K+ permeable but not fully selective for KC. It is resistant to glibenclamide. It is inhibited by BaZ+, 4-aminopyridine. 
Coz+. NiZ+ and W’. 
Follicular Xenopus oocyte: Potassium channel opener; Glibenclamide; ATP-sensitive potassium channel 
1. INTRODUCTION 
The discovery that the vasorelaxant effects of 
BRL34915, most commonly called cromakalim (CK), 
are associated with an hyperpolarization of vascular 
smooth muscle due to K+ channel opening, has recently 
attracted considerable interest [l-3]. There are now 
many different chemical classes of K + channel openers 
(KCOs). The best known compounds in each class are 
cromakalim, pinacidil, nicorandil, minoxidil sulfate, 
diazoxid and RP49356 [4]. 
KCOs have now been shown to have an action not 
only on the vascular smooth muscle cell but also on p- 
pancreatic cells [5] or other types of smooth muscle cells 
[6,7], on cardiac cells [8], on neurons [9], and on 
skeletal muscle cells [lo]. Their target seems to be an 
important class of K+ channels, the ATP-sensitive K + 
(KATP) channels [ 111. 
Ahbrevmtions: CK, cromakalim; KCOs, K channel openers; Ii \, I’ 
channels, ATP-sensitive K ’ channels; HEPES, .W2-hydroxyethyl- 
piperarine-N-2.ethanesulfonic acid; EGTA, ethyleneglycol-bis-(/~- 
aminoethylether),N,N,N ‘,N ‘,-tetraacetic acid; 1-v relationship, cur- 
rent-voltage relationship; TEA ’ , tetraethylammonium; 4AP, 
4.aminopyridine; MCD peptide, mast cell degranulating peptide; 
RP49356, ,L\Lmethyl,2-[-3-pyridil]-tetrahydrothiop~~ran-2-carbothia- 
mide-l-oxide; BRL34915, 6.cyano-3,4-dihydro-2,2-dimethyl-trans- 
4.[2-oxo-1.pyrrolidyll-2H-benzo[b]-pyran-3-01; PlO60, :V-[err-butyl- 
,%‘-cyano-N’ ‘-3.pyridinylguanidine; P1075, N-rerr-pentyl-N’- 
cvano-Y’ ‘-3.pyridinylguanidine. _ 1 
Correspondence uddress: E. HonorC, lnstitut de Pharmacologic 
MolCculaire et Cellulaire du CNRS, 660 routes des Lucioles, Sophia 
Antipolis, 06560 Valbonne, France. Fax: (33) (93) 957704. 
The purpose of this paper is to describe the phar- 
macological properties of action of KCOs in the 
Xenopus oocyte system which turns out to be one of the 
best systems for studying this class of drugs. 
2. MATERIALS AND METHODS 
Xerlopus laei’i.7 were purchased from C.R.B.M. (Montpellier, 
France). Pieces of the ocary were surgically removed and individual 
oocytes were dissected away in a modified Barth’s Folution: 88 mM 
NaCl, I mhI KCI, 2.4 mhl NaHCOI, 0.33 mM Ca(NOJ)z. 0.41 mM 
CaClz, 0.82 mM MgSO?, 10 mM N-2-hydroxyethylpiperazine- 
N’-ethanesulfonic acid (HEPES), pH 7.4 with NaOH. To discard 
follicular cells, stage V and VI oocytes were treated for 2 h with col- 
lagcnatc (I mg ml ‘, Boehringer Xlannheim, Germany) in Barth’, 
medium and then the follicular layer was manually removed with fine 
forceps. Oocytes were kept for 2 to 7 days in Barth’s medium sup- 
plemented with 100 U/ml penicillin and 100 fig/ml streptomycin. 
In a 0.3 ml perfusion chamber, a single oocyte was impaled with 
tmo standard gla\s microelectrode (0.5-2.0 MQ resistance) filled with 
3 M KCI and maintained under voltage clamp using a Da&an 8500 
amplifier. Stimulation of the preparation, data acquiGtion and 
analyses were performed using the pClamp software (Axon In- 
struments, USA). Drugs were applied either externally by addition to 
the superfusate (Gilson peristaltic pump: flow rate: 3 ml min I). 
EGTA was internally applied by pressure injection (Inject + Matic, 
Switzerland) using an additional micropipette (2-4 pm in diameter). 
The injected volume was 0.01-0.02~0 of the cell volume. Saline solu- 
tion (ND 96) of the following composition was used in all procedures 
unless otherwise stated: 96 mM NaCI, 2 mM KCI, 1.X mM CaClz, 2 
mM MgClz, 5 mM HEPES (pH 7.4 with NaOH). All chemicals used 
\\ere from Sigma unless otherwise stated. The variability of the results 
\%a$ cxpre?sed as SEM with n indicating the number of cell\ con- 
tributing to the mean. 
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Fig. I. (A) In a follicle-enctoxd Xer~opuc oocyte 100 pM CK induced 
an h!per-polarization. (B) In the same follicle-enclosed oocyre \ol[age 
clamped a5 ~ 20 mV, IO0 p.Ll C‘K elicited a laye our\+ald current. (C) 
In a defolliculaled oocyte, 100 phi CK induced a depolal-i,wion. (LJ) 
In rhc (ame defolliculaled oocyre voltage clampcd ac ~ 20 m\‘, t(X) 
3. RESULTS 
Fig. 1 compares the effects of KCOs on the elec- 
trophysiological properties of follicle-enclosed and 
defolliculated oocytes. 
Superfusion of a follicle-enclosed Xenopus oocyte 
with 100 PM CK induced a large hyperpolarization (Fig. 
1A). Under control conditions, in the absence of CK, 
the resting membrane potential was ~ 57 k 6 mV (n = 
8). In the presence of 100 PM CK, the cell hyperpolariz- 
ed to -88 + 8 mV (n = 8). In the same cell under 
voltage-clamp conditions, at a holding potential of ~ 20 
mV, CK induced a large outward current (Fig. 1B). 
Conversely, CK induced a membrane depolarization in 
the defolliculated oocyte. In the typical experiment 
presented in Fig. lC, the resting membrane potential of 
a control defolliculated oocyte was ~ 61 + 4 mV (n = 
7). In the presence of 100 PM CK the cell depolarized to 
-49 f 3 mV (n = 7). Voltage-clamp experiments at a 
holding potential of -20 mV show (Fig. ID) that CK 
application to the defolliculated oocyte reveals an in- 
ward current. This inward current will actually be 
shown later to result from the inhibition of an outward 
background current. 
Fig. 2A shows that if in the follicle-enclosed oocyte, 
an outward current was elicited by CK in the presence 
of 2 mM external K + , the current direction was revers- 
ed when the cell was bathed in a 50 mM K+ medium. 
The CK-induced inward current observed in 2 mM K + 
with the defolliculated oocyte became outward in the 
presence of 50 mM K’ (Fig. 2B). 
Current-voltage (I-I/? relationships for the CK- 
modulated currents in follicle-enclosed and 
defolliculated oocytes are presented in Fig. 2C and 2D. 
The CK-induced outward current measured at - 10 mV 
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in the follicle-enclosed oocyte is shoMn in Fig. 2C (in- 
,et). The I-V cur\ze in that case \vas linear between 
~ 140 and 20 mV and then rectified in the inward direc- 
tion for positive potentials (Fig. 2C). The reversal 
potential \vas - 97 -+ 5 mV (n = 9). The inset in Fig. 2D 
shows that CK decreased the ampiitudc of the outward 
current measured after a \,oltage jump from ~ 80 to 60 
mV in a defolliculated oocyte. In that case CK clearlq 
decreased a membrane conductance. The I-C’ curve of 
the current component \\hich is blocked by CK is lineat 
over all the range of potentials tested and the re\,ersal 
potential \vas observed at - 51 k 5 mV (17 = 12). The in- 
hibitory effects of CK remained after removal of ex- 
tracellular Cal+ or loading Lvith intracellular EGTA. 
Fig. 3A compares the relative amplitudes of the out- 
ward currents elicited with 300 ,tM of various KCOs. 
Both (+) and (-)pinacidil \\.ere active although \vith a 
relatively \veak potency. ( - )Pinacidil \vas about t\\;ice 
more effective than the ( + )enantiomer. The pinacidil 
derivatives P1075 and PI060 were about 20 times more 
potent than pinacidil. BRL38227 (also called 
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Fig. 3. (A) Amplitude of the currents elicited by 300 +I KCOs in 
follicles. Numbers of oocytes are indicated and the number of donors 
was at least 3. In all these experiments the holding potential MS - 20 
mV. (B) KCOs dose-effect curw in follicle-enclosed oocytes. Every 
curve is the mean of at least 6 experiments on three different frogs. 
temakalim) induced a current of about the same 
amplitude as PLO60 and Pf075. The f+)enantiomer 
BRL38226 was totahy inactive. The racemate 
BRL34915 (CK) was 2.5 times less potent than the 
(- )enantiomer BRL38227. Among the RP derivatives 
tested, only RP61419 could activate an outward current 
in follicle-enclosed oocytes with a potency of about half 
of that found for CK. Minoxidil sulfate, nicorandil and 
diazoxide at a concentration of 300 PM were also totally 
ineffective (n = 5). The comparative dose-response 
curves for the activation of outward currents in 
foliicular ceils by different KCOs are presented in Fig. 
3A. The rank order of potency wa5 
Pf075>PlOBO>BRL38227>RP61419> (-lpinacidit. 
Fig. 4A compares the efficacy of different KC% us- 
ed at the concentration of 300 &I to inhibit the 
background ionic conductance in the defolliculated 
oocyte. Pinacidil and derivatives were ineffective. CK, 
BRL38226 and RP61419 produced similar effects. 
BRL38227 was three times less effective than 
BRL38226. The other KCOs tested including RP49356, 
minoxidil sulfate, nicorandil and diazoxide did not have 
any inhibitory effect (n = 7). Fig. 4B shows the inhibi- 
tion of the background ionic current in defolficulated 
0.01 0.1 1 10 
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Fig. 4. {A) Amplitude of the current inhibited by 300 UM KCOs in 
defolliculated oocytes. Numbers of oocytes are indicated and the 
number of donors was 4. In all these experiments the holding pnten- 
tial was -20 mV. (B) Dose-effect curke of the inhibition of the 
background current by BRL.38226 on a defolliculated oocyte. Every 
mean data point is the mean oF at least 6 experiments on 4 donors. 
oocytes by the ( + )enantiomer BRL38226. BRL38226 
inhibited 50% of the current at a concentration of 150 
$M. 
Fig. 5 compares the effects of g~jbenc~amjde on both 
types of KCOs sensitive currents. The current 
stimulated by KCOs in the follicle-enclosed oocyte was 
inhibited in a dose-dependent manner by the 
sulfonylurea glibenclamide (Fig. 5A). The background 
current inhibited by KCOs was not altered by 10 FM 
glibenclamide (Fig. 5B). The less specific K+ channel 
blockers tetraethylammonium (TEA’), 4-aminopyri- 
dine (4AP), Cs + and BaZC are known to inhibit the 
outward current elicited by CK in different prepara- 
tions 112,14]. The background current which is blocked 
by BRt38226 and CK was not inhibited by 30 mM 
TEA f and by 20 mM Cs i (data not shown). It was also 
depressed by 3 mM 4AP and abolished by 500 FM Ba2 + 
(Fig. 5B). Similar types of inhibitions were also found 
with 1 mM of Co2+ ) Ni”’ and La3 + (data not shown). 
The different polypeptides and toxins blocking 
voltage- and Ca” -dependent K’ channels such as 
apamin, dendrotoxirr I, MCD peptide, charybdotoxin 
and P-bungarotoxin (100 nM) were inactive on currents 
which are sensitive to KOCs activation or inhibition. 
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Fig. 5. (A) The 100 FM CK-induced outv.ard current recorded at a 
potential of ~ 20 mV was blocked b> increasing concentrations of 
glibenclamide (a5 indicated on curt-ent trace) in a follicle-encloted 
oocytc. (B) In a defolliculated oocyte, voltage-clamped at 20 mV, 
the background current was blocked bk 300 @Xl CK, 3 mVl IAP and 
500 ~111 Ba’ ’ IO phi @ibenclamide did not affect this curl-ent. In 
thew experiments the zero current levels are indicated by arrows. 
4. DISCUSSION 
This paper shows that both the follicle-enclosed 
Xenopus oocyte and defolliculated oocytes have ionic 
channels that are sensitive to KCOs. 
CK, pinacidil and their derivatives activate a K+ 
channel in the foliicular oocyte. The opening of this 
channel produces an important hyperpolarization. The 
KCO-activated K + channels are blocked by the 
sulfonylurea glibenclamide. The current-voltage rela- 
tionship of this channel indicates a rectification for 
membrane potentials higher than + 20 mV. The phar- 
macological properties, i.e. the activation of KCOs and 
the inhibition by glibenclamide and the biophysical 
properties, i.e. the rectification at higher potentials, are 
similar to properties which have been previously 
established for the cardiac ATP-sensitive K + channel 
[S]. However the cardiac K _ channel is much more sen- 
sitive to glibenclamide (Ko.5 = 0.3 nM; [13]) than the 
K’ channel in follicle oocytes (Ko.5 = 200 nM). At a 
concentration of 300 FM, the most potent activators of 
the K + channel in follicular oocytcs are the pinacidil 
derivatives P1060 and P1075 and the (-)enantiomer 
BRL38227 (lemakalim). However, other openers were 
also active and the rank order of potency is PI075 (Ko.5: 
5 PM)> 1060 (Ko 5: I2 @l)>BRL38227 (Ko: 77 
~M)>RP61419(Ko,~: IOO/&I)>(-)pinacidil (Kc),>: 300 
$v~). How does the efficacy of these different com- 
pounds on the follicular oocyte correspond to their 
kno\vn efficacy in other sensitive cell types? In smooth 
muscle both the affinities and the rank order of potency 
of KCOs are different from what is described here for 
the follicular oocyte. The pinacidil derivative P1060 
and P 1075 are more potent than pinacidil [I41 but Ko.5 
\,alues for pinacidil (K~~,~: 0.3 @I) and cromakalim 
(Kc, 5: 20 nhl) are much lo\ver than those described in 
this paper. Also nicorandil and minoxidil sulfate are ac- 
ti\,e [2] in smooth muscle cells Lvhereas they are inactive 
in follicular oocytes. 
The potency of pinacidil and derivati\,es is also 
greater in cardiac cells than in follicular oocytes [1.5]. 
Although in this preparation again one finds that P1075 
and PI060 are more potent than pinacidil. 
In substantia nigra the order of potency of KCOs is 
lemakalim > nicorandil > cromakalim > pinacidil > P1075 
[9]. Again it is clearly different from that found in 
follicular oocytei. 
All these results taken together suggest that the 
Xmopzrs follicular oocytes contain a new subtype of 
KCOs-sensitive K _ channel. 
Defolliculation clearly indicates that the 
KCO/glibenclamide-sensiti\e K + channels are situated 
in follicles and are not present in the oocyte itself. The 
oocyte membrane, however, also contains a channel 
that is altered by some of the KCOs and particularly by 
CK (BRL34915) and by its t\%o enantiomers BRL38227 
and BRL38226. Interestingly Chile the (~ )enantiomer 
BRL38227 is the most active opener of K + channels in 
follicles, the ( + )enantiomer BRL38226 is the most ac- 
tive inhibitor of the oocyte channel. The RP61419 com- 
pound is, like compounds in the BRL series, an active 
opener of the follicular K + channels and an inhibitor of 
the oocyte channel. The channel inhibited in 
defolliculated oocytes is responsible for a background 
current since its inhibition reveals an inward current 
(Fig. 1D). Like many types of K’ currents [16], the 
background current \vhich is inhibited by some of the 
KCOs is also inhibited by Ba’ ’ and 4AP. However this 
current is not inhibited by glibenclamide. The channel 
responsible for this current however is probably not a 
completely selective K + channel since the reversal 
potential is ~ 51 rt- 5 mV (it should have been about 
- 95 mV for a K + channel). The current is also blocked 
by Co* - and Ni” as a background current which had 
been previously identified by Miledi et al. [17]. It seems 
that BRL38226 could be an adequate pharmacological 
tool to gain more information in the future on the pro- 
perties of this particular background current. 
The different molecules studied in this Lvork will pro- 
bably be useful to understand the respective 
physiological roles of the KCOs activated K + channels 
78 
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in follicles and of the KCOs inhibited channel responsi- 
ble for the background current in defolliculated 
oocytes. 
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